Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Merck’s Gabor Outlines AI and Biomedicine Strategy in China
February 4, 2025
Company
Deals
Luye Pharma Grants ICI Pakistan Distribution Rights for Schizophrenia Drug Seroquel
February 4, 2025
Company
Medical Device
Sino Medical Sciences Gains Approval for Drug-Eluting Stent System
February 4, 2025
Company
Drug
Tris Pharma and Pediatrix Therapeutics’ ADHD Drug Gains Priority Review in China
February 4, 2025
Company
Drug
Angel Pharmaceuticals Gains CDE Approval for Mupadolimab Phase I/Ib Study
February 4, 2025
Company
YiChang HEC Reports Strong Recovery in 2022 Interim Results
February 4, 2025
Company
Sino Biopharmaceutical Reports Mixed Results in 2022 Interim Report
February 4, 2025
Company
Deals
Gluetacs Therapeutics Files IND for Molecular Glue Degrading Agent in China
February 4, 2025
Company
Global Cord Blood Corporation Appoints Liquidators Amid Shareholder Dispute
February 4, 2025
Company
Deals
Hansoh Pharmaceutical Licenses KiOmedine One for Osteoarthritis Treatment
February 4, 2025
Company
Deals
Ubrigene Raises Hundreds of Millions in Series C Financing Round
February 4, 2025
Company
Medical Device
China’s First Proton Therapy System Approved by NMPA
February 4, 2025
1
2
…
1,125
1,126
1,127
1,128
1,129
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
